It’s certainly not unusual for members of Congress to question whether an agency is overstepping its bounds. Just last week, several members of the House Energy and Commerce Committee questioned the Office of the National Coordinator for Health IT’s authority to regulate health IT after the Meaningful Use program ends, as well as the extent to which it can regulate health IT at all for non-Meaningful Use initiatives.
